BioCryst Pharmaceuticals, Inc. (BCRX) is near the top in its industry group according to InvestorsObserver. BCRX gets an overall rating of 51. That means it scores higher than 51 percent of stocks. BioCryst Pharmaceuticals, Inc. gets a 81 rank in the Biotechnology industry. Biotechnology is number 104 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With BioCryst Pharmaceuticals, Inc. Stock Today?
BioCryst Pharmaceuticals, Inc. (BCRX) stock has risen 8.8% while the S&P 500 is lower by -0.03% as of 10:02 AM on Thursday, May 6. BCRX is higher by $0.94 from the previous closing price of $10.68 on volume of 1,204,936 shares. Over the past year the S&P 500 is higher by 46.27% while BCRX is higher by 201.04%. BCRX lost -$1.09 per share the over the last 12 months.
Click Here to get the full Stock Score Report on BioCryst Pharmaceuticals, Inc. (BCRX) Stock.
